InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,270.40
(
0.55%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
86.52
(
1.65%
)
Bitcoin
63,182.15
(
0.93%
)
Post# of 19304
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Jagman

Send PM Follow Ignore
Followers 63
Posts 14414
Boards Moderated 0
Alias Born 07/19/2003

Jagman

Re: None

Thursday, 09/29/2005 7:06:50 AM

Thursday, September 29, 2005 7:06:50 AM

Post# of 19304
INSM...Insmed Issues Statement Regarding IPLEX(TM) Approvable Letter Press Release
Thursday September 29, 6:45 am ET

RICHMOND, Va.--(BUSINESS WIRE)--Sept. 29, 2005--Insmed Incorporated (NASDAQ:INSM - News) today released the following statement: The company wishes to clarify a statement in the press release issued September 27, 2005 regarding iPlex (rhIGF-I/rhIGFBP-3) (Mecasermin rinfibate). With respect to the orphan exclusivity issue, Insmed wants to be clear that the FDA has not yet determined whether the recent approval and granting of orphan exclusivity for Mecasermin (rDNA origin) for Severe Primary IGF-1 deficiency will block the approval of iPlex. The Agency is still considering the issue.

Cash is King until further notice!!!

My comments on companies are usually my opinion of long term success (years). The PPS may go up or down greatly in the meantime depending on the number of greedy suckers with money.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up